BioSpace News Archive

Deals

Volition announces $500,000 in Non-Dilutive Funding for Volition Veterinary and issues Video

VolitionRx Limited announced the confirmation of a further $500,000 non-dilutive funding in the form of a loan from the Texas A&M SOFINEX funding agency of the Walloon Region to support the development of its subsidiary Volition Veterinary Diagnostics Development, LLC.

October 29, 2019
·
6 min read
Business

EarlySign Selects Chief Medical Officer Dr. Jeremy Orr as New CEO

Appointment Underscores AI Health Company’s Commitment to Providing Healthcare System-Ready Solutions

October 29, 2019
·
3 min read
Drug Development

DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of VAL-083 at the 2019 Society for NeuroOncology Annual Meeting

Date/Time: Friday, November 22, 2019, 6:00 PM MT Lead Author: Dr. Zhong-Ping Chen

October 29, 2019
·
4 min read
BioCapital

Harris Healthcare Announces AcuityPlus v8.8

Harris Healthcare is pleased to announce the General Availability of AcuityPlus v 8.8, its propriety Acuity-based staffing solution that uses both transparent classification and evidence-based methodologies to address patient acuity, nursing competencies, and patient complexity of care.

October 29, 2019
·
3 min read
Business

IVERIC bio Appoints Abraham Scaria, PhD, as Chief Scientific Officer

Former Genzyme and Sanofi Scientist Brings Extensive Experience in Ocular Gene Therapy with Viral Vectors to IVERIC bio

October 29, 2019
·
4 min read
BioMidwest

How the War on Drugs and Myths about Addiction Have Created a War on All of Us

Written by a lawyer and expert on drug policy and criminal justice reform, the new book War on Us offers a blueprint to address the overdose epidemic while ending the failed War on Drugs.

October 29, 2019
·
3 min read
BioMidwest

Prime Therapeutics Study Finds Tagrisso® New First-line Lung Cancer Treatment Drives Ten-fold Use, $4 Million Cost Increase

A new study from Prime Therapeutics LLC (Prime) shows a ten-fold increase in the use of osimertinib (Tagrisso®) – an epidermal growth factor receptor inhibitor (EGFR-i) – since it became a guideline recommended first-line therapy option in late 2017.

October 29, 2019
·
4 min read
Business

Diagnostics Industry Veteran Dr. Frédéric Sweeney Joins MeMed as Chief Business Development Officer

MeMed Ltd., a leader in host response-based diagnostic solutions, announced the addition of Dr. Frédéric Sweeney to its executive team as Chief Business Development Officer.

October 29, 2019
·
3 min read
WAT Medical will be returning to 2019 MEDICA to exhibit their innovative wearable technologies

From November 18-21, 2019, WAT Medical will be showcasing their EmeTerm, the anti-vomiting wristband, and HeadaTerm, the anti-migraine head patch, at one of the largest healthcare trade shows, MEDICA, in Dusseldorf, Germany at Stand Hall 16/H40.

October 29, 2019
·
3 min read
Deals

Activ Surgical Readies for 2020 Commercial Launch; Closes Additional $11 Million from Series A Round

Activ Surgical, a pioneering digital intelligence company focused on improving surgical efficiency, accuracy, patient outcomes and accessibility, announced the close of an additional $11 million from Series A round funding.

October 29, 2019
·
4 min read